What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial

Zara Margarite Sayar, Julia Czuprynska, Jignesh Prakash Patel, Reuben Benjamin, Lara Roberts, Raj K. Patel, Victoria Cornelius, Roopen Arya

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)
139 Downloads (Pure)

Fingerprint

Dive into the research topics of 'What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial'. Together they form a unique fingerprint.

Medicine and Dentistry